ClinicalTrials.gov
ClinicalTrials.gov Menu

ShearWave™ Elastography of Breast Lesions in Chinese Patients (BE3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02226081
Recruitment Status : Completed
First Posted : August 26, 2014
Last Update Posted : April 19, 2016
Sponsor:
Information provided by (Responsible Party):
SuperSonic Imagine

Brief Summary:
We aim to determine if adding ShearWave Elastography to a standard ultrasound breast exam can improve the characterization (classification) of breast lesions.

Condition or disease
Breast Neoplasms

Detailed Description:
Chinese women are known to have denser breasts than women in Western countries. Mammography cannot find abnormalities easily in denser breasts, while breast ultrasound is not affected by density. Adding elastography, a stiffness measurement, to a breast ultrasound exam should improve the diagnosis of a lesion.

Study Type : Observational
Actual Enrollment : 2273 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Assessment of ShearWave™ Elastography in the Ultrasonic Diagnosis of Breast Cancer in Chinese Patients
Study Start Date : June 2014
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound




Primary Outcome Measures :
  1. Increase in specificity of breast ultrasound imaging when considering stiffness measurements [ Time Frame: Within 18 months of the study start date ]

Secondary Outcome Measures :
  1. Change of sensitivity and negative predictive value of breast ultrasound imaging when considering stiffness measurements [ Time Frame: Within 18 months of the study start date ]
  2. Increase in positive predictive value for biopsy of breast ultrasound when considering stiffness measurements [ Time Frame: within 18 months of the study start date ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Chinese women (age of majority) who have been referred to a hospital or clinical for a breast ultrasound evaluation.
Criteria

Inclusion Criteria:

  • female
  • 18 years of age or older
  • known breast lesion that has not been managed or treated
  • referred for a breast ultrasound because of a breast mass found on at least one of the following examinations:

    • physical palpation
    • mammography
    • ultrasound exam
    • MRI

Exclusion Criteria:

  • Women who are unwilling or unable to provide informed consent
  • Women with breast implants
  • Women who are pregnant or breastfeeding
  • Women in whom all lesions are diagnostically categorized as BI-RADS 0, 1 or 6
  • Women with previous ipsilateral breast surgery
  • Women with no visible breast mass on ultrasound examination
  • Women with axillary metastatic lymph nodes only
  • Women with foreign body in the breast
  • Women who are not Chinese nationality

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02226081


Locations
China
1st Affiliated Hospital of PLAGH (304)
Beijing, China
Beijing Friendship Hospital, Capital Medical University
Beijing, China
People's Liberation Army General Hospital (301)
Beijing, China
Affiliated Hospital of Binzhou Medical University
Binzhou, China
Sichuan Provincial People's Hospital
Chengdu, China
West China Hospital, Sichuan University
Chengdu, China
Fujian Provincial Cancer Hospital
Fuzhou, China
Guangdong Provincial Traditional Chinese Medical Hospital
Guangzhou, China
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, China
Sun-Yat Sen University Cancer Center
Guangzhou, China
1st Affiliated Hospital of Harbin University
Harbin, China
Hefei 2nd People's Hospital
Hefei, China
Jiangsu Provincial Hospital
Nanjing, China
Yinzhou People's Hospital
Ningbo, China
Fudan University Cancer Center
Shanghai, China
1st Affiliated Hospital of China Medical University
Shenyang, China
4th Affiliated Hospital of China Medical University
Shenyang, China
Shengjing Hospital of China Medical University
Shenyang, China
General Hospital of TISCO
Taiyuan, China
Shanxi Dayi Hospital
Taiyuan, China
1st Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
1st Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Sponsors and Collaborators
SuperSonic Imagine
Investigators
Principal Investigator: Cai Chang Fudan University
Principal Investigator: Anhua Li Sun Yat-sen University

Responsible Party: SuperSonic Imagine
ClinicalTrials.gov Identifier: NCT02226081     History of Changes
Other Study ID Numbers: BE3
ChiCTR-DDT-14004785 ( Registry Identifier: China Clinical Trial )
First Posted: August 26, 2014    Key Record Dates
Last Update Posted: April 19, 2016
Last Verified: April 2016

Keywords provided by SuperSonic Imagine:
breast lesion
ultrasound
BI-RADS
women
malignancy

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases